Ryan Demeter
Overview
Explore the profile of Ryan Demeter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
2369
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Linette G, Becker-Hapak M, Skidmore Z, Baroja M, Xu C, Hundal J, et al.
Proc Natl Acad Sci U S A
. 2019 Nov;
116(47):23662-23670.
PMID: 31685621
The impact of intratumoral heterogeneity (ITH) and the resultant neoantigen landscape on T cell immunity are poorly understood. ITH is a widely recognized feature of solid tumors and poses distinct...
2.
Wong T, Miller C, Klco J, Petti A, Demeter R, Helton N, et al.
Blood
. 2015 Dec;
127(7):893-7.
PMID: 26631115
There is interest in using leukemia-gene panels and next-generation sequencing to assess acute myelogenous leukemia (AML) response to induction chemotherapy. Studies have shown that patients with AML in morphologic remission...
3.
Tevz G, McGrath S, Demeter R, Magrini V, Jeet V, Rockstroh A, et al.
Mol Cell Endocrinol
. 2015 Oct;
420:159-68.
PMID: 26499396
Simultaneous expression of highly homologous RLN1 and RLN2 genes in prostate impairs their accurate delineation. We used PacBio SMRT sequencing and RNA-Seq in LNCaP cells in order to dissect the...
4.
Hughes A, Magrini V, Demeter R, Miller C, Fulton R, Fulton L, et al.
PLoS Genet
. 2014 Jul;
10(7):e1004462.
PMID: 25010716
Next-generation sequencing has been used to infer the clonality of heterogeneous tumor samples. These analyses yield specific predictions-the population frequency of individual clones, their genetic composition, and their evolutionary relationships-which...
5.
Cabanski C, Magrini V, Griffith M, Griffith O, McGrath S, Zhang J, et al.
J Mol Diagn
. 2014 May;
16(4):440-51.
PMID: 24814956
The use of massively parallel sequencing for studying RNA expression has greatly enhanced our understanding of the transcriptome through the myriad ways these data can be characterized. In particular, clinical...
6.
Gutmann D, McLellan M, Hussain I, Wallis J, Fulton L, Fulton R, et al.
Genome Res
. 2012 Dec;
23(3):431-9.
PMID: 23222849
Low-grade brain tumors (pilocytic astrocytomas) arising in the neurofibromatosis type 1 (NF1) inherited cancer predisposition syndrome are hypothesized to result from a combination of germline and acquired somatic NF1 tumor...
7.
Ellis M, Ding L, Shen D, Luo J, Suman V, Wallis J, et al.
Nature
. 2012 Jun;
486(7403):353-60.
PMID: 22722193
To correlate the variable clinical features of oestrogen-receptor-positive breast cancer with somatic alterations, we studied pretreatment tumour biopsies accrued from patients in two studies of neoadjuvant aromatase inhibitor therapy by...
8.
Iossifov I, Ronemus M, Levy D, Wang Z, Hakker I, Rosenbaum J, et al.
Neuron
. 2012 May;
74(2):285-99.
PMID: 22542183
Exome sequencing of 343 families, each with a single child on the autism spectrum and at least one unaffected sibling, reveal de novo small indels and point substitutions, which come...
9.
Matsushita H, Vesely M, Koboldt D, Rickert C, Uppaluri R, Magrini V, et al.
Nature
. 2012 Feb;
482(7385):400-4.
PMID: 22318521
Cancer immunoediting, the process by which the immune system controls tumour outgrowth and shapes tumour immunogenicity, is comprised of three phases: elimination, equilibrium and escape. Although many immune components that...